purchase customization

1 Cystic Fibrosis Drugs Market Overview
1.1 Product Overview and Scope of Cystic Fibrosis Drugs
1.2 Cystic Fibrosis Drugs Segment by Type
1.2.1 Global Cystic Fibrosis Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral Cystic Fibrosis Drugs
1.2.3 Injection Cystic Fibrosis Drugs
1.3 Cystic Fibrosis Drugs Segment by Application
1.3.1 Global Cystic Fibrosis Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Cystic Fibrosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Cystic Fibrosis Drugs Revenue 2017-2028
1.4.2 Global Cystic Fibrosis Drugs Sales 2017-2028
1.4.3 Cystic Fibrosis Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Cystic Fibrosis Drugs Market Competition by Manufacturers
2.1 Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Cystic Fibrosis Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Cystic Fibrosis Drugs Manufacturing Sites, Area Served, Product Type
2.5 Cystic Fibrosis Drugs Market Competitive Situation and Trends
2.5.1 Cystic Fibrosis Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cystic Fibrosis Drugs Players Market Share by Revenue
2.5.3 Global Cystic Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cystic Fibrosis Drugs Retrospective Market Scenario by Region
3.1 Global Cystic Fibrosis Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Cystic Fibrosis Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Cystic Fibrosis Drugs Market Facts & Figures by Country
3.3.1 North America Cystic Fibrosis Drugs Sales by Country
3.3.2 North America Cystic Fibrosis Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cystic Fibrosis Drugs Market Facts & Figures by Country
3.4.1 Europe Cystic Fibrosis Drugs Sales by Country
3.4.2 Europe Cystic Fibrosis Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cystic Fibrosis Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Cystic Fibrosis Drugs Sales by Region
3.5.2 Asia Pacific Cystic Fibrosis Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Cystic Fibrosis Drugs Market Facts & Figures by Country
3.6.1 Latin America Cystic Fibrosis Drugs Sales by Country
3.6.2 Latin America Cystic Fibrosis Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cystic Fibrosis Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Cystic Fibrosis Drugs Sales by Country
3.7.2 Middle East and Africa Cystic Fibrosis Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cystic Fibrosis Drugs Historic Market Analysis by Type
4.1 Global Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)
4.2 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Cystic Fibrosis Drugs Price by Type (2017-2022)
5 Global Cystic Fibrosis Drugs Historic Market Analysis by Application
5.1 Global Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)
5.2 Global Cystic Fibrosis Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Cystic Fibrosis Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Actavis
6.1.1 Actavis Corporation Information
6.1.2 Actavis Description and Business Overview
6.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Actavis Cystic Fibrosis Drugs Product Portfolio
6.1.5 Actavis Recent Developments/Updates
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Corporation Information
6.2.2 F. Hoffmann-La Roche Description and Business Overview
6.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
6.3 Gilead Sciences
6.3.1 Gilead Sciences Corporation Information
6.3.2 Gilead Sciences Description and Business Overview
6.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
6.3.5 Gilead Sciences Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Cystic Fibrosis Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Vertex Pharmaceuticals
6.5.1 Vertex Pharmaceuticals Corporation Information
6.5.2 Vertex Pharmaceuticals Description and Business Overview
6.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.5.5 Vertex Pharmaceuticals Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Abbott Cystic Fibrosis Drugs Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Anthera Pharmaceuticals
6.6.1 Anthera Pharmaceuticals Corporation Information
6.6.2 Anthera Pharmaceuticals Description and Business Overview
6.6.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.7.5 Anthera Pharmaceuticals Recent Developments/Updates
6.8 Arcturus Therapeutics
6.8.1 Arcturus Therapeutics Corporation Information
6.8.2 Arcturus Therapeutics Description and Business Overview
6.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.8.5 Arcturus Therapeutics Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Chiesi Farmaceutici
6.10.1 Chiesi Farmaceutici Corporation Information
6.10.2 Chiesi Farmaceutici Description and Business Overview
6.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
6.10.5 Chiesi Farmaceutici Recent Developments/Updates
6.11 Corbus Pharmaceuticals
6.11.1 Corbus Pharmaceuticals Corporation Information
6.11.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Description and Business Overview
6.11.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.11.5 Corbus Pharmaceuticals Recent Developments/Updates
6.12 Genzyme
6.12.1 Genzyme Corporation Information
6.12.2 Genzyme Cystic Fibrosis Drugs Description and Business Overview
6.12.3 Genzyme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Genzyme Cystic Fibrosis Drugs Product Portfolio
6.12.5 Genzyme Recent Developments/Updates
6.13 Insmed
6.13.1 Insmed Corporation Information
6.13.2 Insmed Cystic Fibrosis Drugs Description and Business Overview
6.13.3 Insmed Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Insmed Cystic Fibrosis Drugs Product Portfolio
6.13.5 Insmed Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Corporation Information
6.14.2 Johnson & Johnson Cystic Fibrosis Drugs Description and Business Overview
6.14.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
6.15 Merck Sharp & Dohme
6.15.1 Merck Sharp & Dohme Corporation Information
6.15.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Description and Business Overview
6.15.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
6.15.5 Merck Sharp & Dohme Recent Developments/Updates
6.16 Neovii Biotech
6.16.1 Neovii Biotech Corporation Information
6.16.2 Neovii Biotech Cystic Fibrosis Drugs Description and Business Overview
6.16.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
6.16.5 Neovii Biotech Recent Developments/Updates
6.17 Novo Nordisk
6.17.1 Novo Nordisk Corporation Information
6.17.2 Novo Nordisk Cystic Fibrosis Drugs Description and Business Overview
6.17.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
6.17.5 Novo Nordisk Recent Developments/Updates
6.18 PharmaSwiss
6.18.1 PharmaSwiss Corporation Information
6.18.2 PharmaSwiss Cystic Fibrosis Drugs Description and Business Overview
6.18.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.18.4 PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
6.18.5 PharmaSwiss Recent Developments/Updates
6.19 Pharmaxis
6.19.1 Pharmaxis Corporation Information
6.19.2 Pharmaxis Cystic Fibrosis Drugs Description and Business Overview
6.19.3 Pharmaxis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Pharmaxis Cystic Fibrosis Drugs Product Portfolio
6.19.5 Pharmaxis Recent Developments/Updates
6.20 Proteostasis Therapeutics
6.20.1 Proteostasis Therapeutics Corporation Information
6.20.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Description and Business Overview
6.20.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.20.5 Proteostasis Therapeutics Recent Developments/Updates
6.21 PTC Therapeutics
6.21.1 PTC Therapeutics Corporation Information
6.21.2 PTC Therapeutics Cystic Fibrosis Drugs Description and Business Overview
6.21.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.21.4 PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.21.5 PTC Therapeutics Recent Developments/Updates
6.22 United Medical
6.22.1 United Medical Corporation Information
6.22.2 United Medical Cystic Fibrosis Drugs Description and Business Overview
6.22.3 United Medical Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.22.4 United Medical Cystic Fibrosis Drugs Product Portfolio
6.22.5 United Medical Recent Developments/Updates
6.23 Venus Remedies
6.23.1 Venus Remedies Corporation Information
6.23.2 Venus Remedies Cystic Fibrosis Drugs Description and Business Overview
6.23.3 Venus Remedies Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Venus Remedies Cystic Fibrosis Drugs Product Portfolio
6.23.5 Venus Remedies Recent Developments/Updates
7 Cystic Fibrosis Drugs Manufacturing Cost Analysis
7.1 Cystic Fibrosis Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs
7.4 Cystic Fibrosis Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cystic Fibrosis Drugs Distributors List
8.3 Cystic Fibrosis Drugs Customers
9 Cystic Fibrosis Drugs Market Dynamics
9.1 Cystic Fibrosis Drugs Industry Trends
9.2 Cystic Fibrosis Drugs Market Drivers
9.3 Cystic Fibrosis Drugs Market Challenges
9.4 Cystic Fibrosis Drugs Market Restraints
10 Global Market Forecast
10.1 Cystic Fibrosis Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cystic Fibrosis Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Cystic Fibrosis Drugs by Type (2023-2028)
10.2 Cystic Fibrosis Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cystic Fibrosis Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Cystic Fibrosis Drugs by Application (2023-2028)
10.3 Cystic Fibrosis Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cystic Fibrosis Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Cystic Fibrosis Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer